PL2167095T3 - Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych - Google Patents

Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych

Info

Publication number
PL2167095T3
PL2167095T3 PL08762390T PL08762390T PL2167095T3 PL 2167095 T3 PL2167095 T3 PL 2167095T3 PL 08762390 T PL08762390 T PL 08762390T PL 08762390 T PL08762390 T PL 08762390T PL 2167095 T3 PL2167095 T3 PL 2167095T3
Authority
PL
Poland
Prior art keywords
cognitive impairment
mild cognitive
treating mild
phenothiazine compounds
phenothiazine
Prior art date
Application number
PL08762390T
Other languages
English (en)
Polish (pl)
Inventor
Claude Michel Wischik
Dominic Venay Harbaran
Gernot Riedel
Serena Deiana
Elizabeth Anne Goatman
Damon Jude Wischik
Alison Dorothy Murray
Roger Todd Staff
Original Assignee
Wista Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Lab Ltd filed Critical Wista Lab Ltd
Publication of PL2167095T3 publication Critical patent/PL2167095T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08762390T 2007-06-19 2008-06-17 Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych PL2167095T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94500607P 2007-06-19 2007-06-19
PCT/GB2008/002066 WO2008155533A2 (en) 2007-06-19 2008-06-17 Phenothiazine compounds for treating mild cognitive impairment
EP08762390.6A EP2167095B1 (en) 2007-06-19 2008-06-17 Phenothiazine compounds for treating mild cognitive impairment

Publications (1)

Publication Number Publication Date
PL2167095T3 true PL2167095T3 (pl) 2019-11-29

Family

ID=39943003

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08762390T PL2167095T3 (pl) 2007-06-19 2008-06-17 Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych

Country Status (16)

Country Link
US (1) US9211294B2 (cg-RX-API-DMAC7.html)
EP (1) EP2167095B1 (cg-RX-API-DMAC7.html)
JP (1) JP5725605B2 (cg-RX-API-DMAC7.html)
CN (1) CN101820884B (cg-RX-API-DMAC7.html)
AU (1) AU2008265045B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0813670A2 (cg-RX-API-DMAC7.html)
CA (1) CA2690746C (cg-RX-API-DMAC7.html)
DK (1) DK2167095T3 (cg-RX-API-DMAC7.html)
ES (1) ES2739546T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191513T1 (cg-RX-API-DMAC7.html)
HU (1) HUE045460T2 (cg-RX-API-DMAC7.html)
MY (1) MY177001A (cg-RX-API-DMAC7.html)
PL (1) PL2167095T3 (cg-RX-API-DMAC7.html)
PT (1) PT2167095T (cg-RX-API-DMAC7.html)
SI (1) SI2167095T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008155533A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109384741B (zh) 2006-03-29 2023-01-06 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物盐及其用途
PL2205245T3 (pl) * 2007-10-03 2015-12-31 Wista Lab Ltd Zastosowanie terapeutyczne diaminofenotiazyn
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
JP5868955B2 (ja) 2010-04-30 2016-02-24 プロセッタ アンチバイラル インコーポレイテッド 抗ウイルス化合物
AU2011358840B2 (en) * 2011-02-11 2017-05-04 TauRx Therapeutics Management Ltd Phenothiazine diaminium salts and their use
PL3470390T3 (pl) * 2013-01-30 2023-11-06 Ecolab Usa Inc. Zmiatacze siarkowodoru
US10304006B2 (en) * 2013-02-15 2019-05-28 The Charles Stark Draper Laboratory, Inc. Method for integrating and fusing heterogeneous data types to perform predictive analysis
WO2016133995A1 (en) * 2015-02-17 2016-08-25 Arizona Board Of Regents On Behalf Of Arizona State University Phenothiazine analogues as mitochondrial therapeutic agents
EP4223297A3 (en) * 2016-07-25 2023-11-15 WisTa Laboratories Ltd. Administration and dosage of diaminophenothiazines
GB201614834D0 (en) * 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
FI3826639T3 (fi) * 2018-07-26 2024-10-30 Wista Lab Ltd Diaminofenotiatsiinien optimoitu annostus populaatioille
MY209608A (en) * 2019-04-10 2025-07-24 Genting Taurx Diagnostic Centre Sdn Bhd Adaptive neurological testing method
GB201909454D0 (en) 2019-07-01 2019-08-14 Wista Lab Ltd Enhancers
GB201909493D0 (en) 2019-07-01 2019-08-14 Wista Lab Ltd Therapeutic interactions
GB201909506D0 (en) 2019-07-02 2019-08-14 Wista Lab Ltd Synaptopathies
CA3257856A1 (en) 2022-05-31 2023-12-07 Wista Laboratories Ltd. TREATMENT OF NEURODEGENERATIVE DISORDERS USING COMPOUNDS CONTAINING METHYLTHIONINIUM (MT)
AU2024231880A1 (en) 2023-03-03 2025-09-11 Taurx Therapeutics Management Ltd. Diaminophenothiazine for the treatment of microvascular brain disease disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) * 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0017060D0 (en) * 2000-07-11 2000-08-30 Hunter Fleming Ltd Production, stabilisation and use of reduced forms of pharmaceutical compounds
GB0101049D0 (en) * 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
WO2004087160A1 (en) * 2003-04-03 2004-10-14 Prana Biotechnology Ltd Treatment of neurological conditions
PT1799662E (pt) * 2004-09-23 2013-07-09 Wista Lab Ltd Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
WO2006091728A2 (en) * 2005-02-24 2006-08-31 The Trustees Of The University Of Pennsylvania Microtubule stabilizing compounds and methods of their use
EP2001556B1 (en) * 2006-03-29 2014-10-01 Wista Laboratories Ltd. Thioninium compounds and their use
CN101460157B (zh) * 2006-03-29 2015-09-02 维斯塔实验室有限公司 蛋白聚集抑制剂
CN109384741B (zh) * 2006-03-29 2023-01-06 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物盐及其用途
DK2457904T3 (en) 2006-07-11 2015-01-12 Wista Lab Ltd Methods for the synthesis and / or purification of the compounds diaminophenothiazinium

Also Published As

Publication number Publication date
CN101820884A (zh) 2010-09-01
SI2167095T1 (sl) 2019-09-30
WO2008155533A3 (en) 2009-02-19
MY177001A (en) 2020-09-01
JP5725605B2 (ja) 2015-05-27
PT2167095T (pt) 2019-08-06
EP2167095B1 (en) 2019-05-29
AU2008265045B2 (en) 2014-02-27
HUE045460T2 (hu) 2019-12-30
DK2167095T3 (da) 2019-07-29
BRPI0813670A2 (pt) 2014-12-30
US20100184752A1 (en) 2010-07-22
CN101820884B (zh) 2013-08-28
WO2008155533A2 (en) 2008-12-24
EP2167095A2 (en) 2010-03-31
CA2690746A1 (en) 2008-12-24
AU2008265045A1 (en) 2008-12-24
JP2010530403A (ja) 2010-09-09
CA2690746C (en) 2018-01-02
ES2739546T3 (es) 2020-01-31
HRP20191513T1 (hr) 2019-11-29
US9211294B2 (en) 2015-12-15

Similar Documents

Publication Publication Date Title
PT2167095T (pt) Compostos de fenotiazina para o tratamento de comprometimento cognitivo leve
EP2504011A4 (en) METHOD FOR TREATING EASY COGNITIVE IMPAIRMENT
IL209895A0 (en) Compounds for treating beta-amyloidoses
GB2445465B (en) Process for waste treatment
IL198851A0 (en) Methods for treating hypercholesterolemia
EP2079414A4 (en) SYSTEM FOR CHEMOHYPER THERMAL TREATMENT
EP1877055A4 (en) 4-AMINOQUINOLINE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASE CONDITIONS
AP2009004746A0 (en) Process for prepaiIrng diaminophenothiazinium compounds
LT3028716T (lt) Komplemento slopinimas nervų regeneracijos pagerinimui
ZA200809528B (en) Treatment for depressive disorders
PL2001892T3 (pl) Imidazolotiazolowe związki do leczenia chorób proliferacyjnych
AU2007288337A8 (en) Compounds for treating proliferative disorders
IL193410A0 (en) Purification method for effluent
ZA200809527B (en) Treatment for depressive disorders
IL213398A0 (en) Compounds for treating cancer
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
IL198856A0 (en) Compounds useful for treating neurodegenerative disorders
GB0810364D0 (en) Improved effluent treatment
PT2481407T (pt) Compostos para utilização no tratamento de distúrbios cognitivos
ZA201002993B (en) Novel compounds for fabric treatment
IL209947A (en) Compounds for the treatment of corneal inflammation
GB0707556D0 (en) Treatment for cancer
ZA200901672B (en) Compounds for treating proliferative disorders
IL205752A0 (en) Octahydroquinolizines for antidiabetic treatment
PL2043792T3 (pl) System do obróbki ciągłej